Leadership & Pay ·
Kura Oncology appointed Jennifer Fulk as its new Chief Financial Officer and principal accounting officer effective…
KURAKura Oncology, Inc.
Kura Oncology appointed Jennifer Fulk as its new Chief Financial Officer and principal accounting officer effective September 8, 2026. She replaces Troy E. Wilson in the CFO role and Thomas Doyle as principal accounting officer. Her compensation package includes a $550,000 annual base salary, an option to purchase 450,000 shares, and restricted stock units covering 173,438 shares. The filing details specific severance terms tied to potential corporate transactions. Kura Oncology operates in the biotechnology industry, focusing on the discovery and development of targeted therapies for cancer.